Abstract
A fast, specific, sensitive high-performance liquid chromatographic method for the determination of cefmetazole in human serum was developed. The serum samples were deproteinized by adding 5% trichloroacetic acid in methanol containing barbital as an internal standard and were injected onto a reverse-phase column (mu-Bondapak C18) with a mobile phase of 10 to 15% acetonitrile in 0.005 M citrate buffer (pH 5.4). Eluted components were detected by UV absorption at 254 nm. Cefmetazole and the internal standard were separated from interfering serum components by this method. The peak height ratio of cefmetazole to the internal standard was proportional to the cefmetazole concentration in the range from 0.4 to 100 micrograms/ml. Serum samples obtained from three patients after a single intravenous injection of cefmetazole were assayed by this method and by a microbiological method. There was a good correlation between two assay methods (correlation, coefficient, 0.98). The stability of cefmetazole in human serum was (correlation coefficient, 0.98). The stability of cefmetazole in human serum was also determined by this method. Cefmetazole was stable in human serum for 2 weeks at 4 degrees C or for at least 8 weeks if it was kept frozen. As the high-performance liquid chromatography method is simple, specific, accurate, and reproducible, it appears to be more suitable for routine assay of cephalosporins than other assay methods.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Aikawa R., Nakano M., Arita T. Fluorometric determination of cephalexin in urine. Chem Pharm Bull (Tokyo) 1976 Oct;24(10):2350–2355. doi: 10.1248/cpb.24.2350. [DOI] [PubMed] [Google Scholar]
- Carling P. C., Idelson B. A., Casano A. A., Alexander E. A., McCabe W. R. Nephrotoxicity associated with cephalothin administration. Arch Intern Med. 1975 Jun;135(6):797–801. [PubMed] [Google Scholar]
- Pasternak D. P., Stephens B. G. Reversible nephrotoxicity associated with cephalothin therapy. Arch Intern Med. 1975 Apr;135(4):599–602. [PubMed] [Google Scholar]
- Sanders W. E., Jr, Johnson J. E., 3rd, Taggart J. G. Adverse reactions to cephalothin and cephapirin. Uniform occurrence on prolonged intravenous administration of high doses. N Engl J Med. 1974 Feb 21;290(8):424–429. doi: 10.1056/NEJM197402212900803. [DOI] [PubMed] [Google Scholar]
- Simpson I. J. Nephrotoxicity and acute renal failure associated with cephalothin and cephaloridine. N Z Med J. 1971 Nov;74(474):312–315. [PubMed] [Google Scholar]
- Tune B. M. Effect of organic acid transport inhibitors on renal cortical uptake and proximal tubular toxicity of cephaloridine. J Pharmacol Exp Ther. 1972 May;181(2):250–256. [PubMed] [Google Scholar]
- Yu A. B., Nightingale C. H., Flanagan D. R. Rapid sensitive fluorometric analysis of cephalosporin antibiotics. J Pharm Sci. 1977 Feb;66(2):213–216. doi: 10.1002/jps.2600660220. [DOI] [PubMed] [Google Scholar]